The use of computed tomography in pediatrics and the associated radiation exposure and estimated cancer risk computed tomography in pediatrics
JAMA Pediatrics, 06/13/2013
Miglioretti DL et al. – Increased use of computed tomography (CT) in pediatrics raises concerns about cancer risk from exposure to ionizing radiation. The increased use of CT in pediatrics, combined with the wide variability in radiation doses, has resulted in many children receiving a high–dose examination. Dose–reduction strategies targeted to the highest quartile of doses could dramatically reduce the number of radiation–induced cancers.
To quantify trends in the use of CT in pediatrics and the associated radiation exposure and cancer risk.
Retrospective observational study.
Seven US health care systems.
The use of CT was evaluated for children younger than 15 years of age from 1996 to 2010, including 4 857 736 child-years of observation.
Radiation doses were calculated for 744 CT scans performed between 2001 and 2011.
The use of CT doubled for children younger than 5 years of age and tripled for children 5 to 14 years of age between 1996 and 2005, remained stable between 2006 and 2007, and then began to decline.
Effective doses varied from 0.03 to 69.2 mSv per scan.
An effective dose of 20 mSv or higher was delivered by 14% to 25% of abdomen/pelvis scans, 6% to 14% of spine scans, and 3% to 8% of chest scans.
Projected lifetime attributable risks of solid cancer were higher for younger patients and girls than for older patients and boys, and they were also higher for patients who underwent CT scans of the abdomen/pelvis or spine than for patients who underwent other types of CT scans.
For girls, a radiation-induced solid cancer is projected to result from every 300 to 390 abdomen/pelvis scans, 330 to 480 chest scans, and 270 to 800 spine scans, depending on age.
The risk of leukemia was highest from head scans for children younger than 5 years of age at a rate of 1.9 cases per 10 000 CT scans.
Nationally, 4 million pediatric CT scans of the head, abdomen/pelvis, chest, or spine performed each year are projected to cause 4870 future cancers.
Reducing the highest 25% of doses to the median might prevent 43% of these cancers.
MDLinx connects healthcare professionals and patients to tomorrow's important medical news, while providing the pharmaceutical and healthcare industries with highly targeted interactive marketing, education, content, and medical research solutions.